Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Multiple Alkalinizing Agents on Urinary Stone Risk Parameters
NCT04651088Phase 1Not yet recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2026
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of potassium citrate, sodium bicarbonate, Litholyte and potassium bicarbonate in nephrolithiasis (6 arms), sponsored by UT Southwestern Medical Center. Primary endpoints: 24 hour urine volume at Day 12, 24 hour urine creatinine at Day 12 and 11 more. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
potassium citratesodium bicarbonateLitholytepotassium bicarbonate
03
Conditions
nephrolithiasis
Beyond the preview
Go deeper on NCT04651088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04651088.